Anticonvulsants: Clinical Trials

25 trials of Anticonvulsants, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

16 completed, 3 terminated, 3 unknown, 1 active not recruiting. 6 Not applicable, 6 Phase 3, 5 Phase 4, 4 Phase 2, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable6Completed 5, Unknown 1
Phase 36Completed 6
Phase 45Terminated 3, Completed 1, Unknown 1
Phase 24Completed 3, Unknown 1
Phase 12Completed 2

Follow Anticonvulsants: new trials by email Literature Review of Anticonvulsants trials Research Report on Anticonvulsants

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Psychoactive Drug Use and Acute Care Use After Trauma and Out-of-Hospital Cardiac Arrest
Opioids (ATC N02A), Antiepileptics (ATC N03A), Antipsychotics (ATC N05A) - Wounds and Injuries, Out-of-Hospital Cardiac Arrest
Active not recruitingAzienda Usl di Bologna527202026-06-102026-10-20
Prophylactic Anti-epileptic Regimen in Traumatic Brain Injury
Anti-Epileptic - Antiepileptic Efficacy and Safety, Brain Injuries
Not yet recruitingAssiut University702026-05-012026-04-17
The Efficacy of Tianeptine Versus Pregabalin on Acute and Chronic Post Mastectomy Pain After Breast Cancer Surgery.
Pregabalin, Tianeptine - Post-mastectomy Pain Syndrome
Not applicableCompletedNational Cancer Institute, Egypt902023-06-212025-03-10
The Efficacy and Safety of Minocycline in the Treatment of Drug-resistant Epilepsy in NORSE Patients
minocycline - Epileptic Seizures Related to Drugs
Not applicableUnknownXijing Hospital252023-03-012023-07-24
Antiepileptic Drugs in Elderly Patients
antiepileptic drugs - Seizure, Epileptic
RecruitingWei Zhao5002021-01-012022-07-15
Seizures and Traumatic Brain Injury Rehabilitation
Antiepileptic Drug - Seizures, Traumatic Brain Injury
CompletedIstituti Clinici Scientifici Maugeri SpA842021-01-012025-05-14
Perampanel for the Reduction of Seizure Frequency in Patients With High-grade Glioma and Focal Epilepsy
Anticonvulsant Agent, Perampanel, Quality-of-Life Assessment - Intractable Epilepsy, Malignant Glioma
Phase 4TerminatedMayo Clinic42020-12-042023-06-22
Rapid Determination Of The Clinical Utility Of Perampanel For The Treatment Of Alcohol Dependence
Perampanel, Placebo - Alcoholism
Phase 1 / Phase 2CompletedVirginia Commonwealth University222019-06-012023-08-18
Aspirin as an add-on Treatment of Refractory Epilepsy in Tuberous Sclerosis Complex
Aspirin, AED, Placebo - Tuberous Sclerosis Complex, Aspirin
Phase 2UnknownPeking Union Medical College Hospital982017-11-202020-06-09
Pharmacokinetics of Paracetamol and Antiepileptic Drugs After Sleeve Gastrectomy
Paracetamol, Antiepileptic (either carbamazepine, lamotrigine, phenytoin or valproic acid) - Bariatric Surgery Candidate
Phase 4TerminatedRambam Health Care Campus22017-07-012021-09-24
Multicentre Study on Rapid Versus Slow Withdrawal of Antiepileptic Monotherapy
Rapid withdrawal of antiepileptic, Slow withdrawal of antiepileptic - Epilepsy
Not applicableCompletedUniversity Magna Graecia482017-04-262022-02-11
Role of Clinical Pharmacists in Epilepsy Management
Optimizing therapy with antiepileptic drugs (carbamazepine, phenytoin, valproic acid) - Epilepsy
Phase 4CompletedGia Dinh People Hospital1412016-01-012021-08-02
Efficacy, Tolerability and Adherence of the Modified Atkins Diet on Drug-resistant Epilepsy
modified adkins diet, Pharmacotherapy without diet - Epilepsy, Drug Resistant
Not applicableCompletedInstituto Mexicano del Seguro Social142015-09-012017-06-09
Immunological and Viral Parameters in Patients Receiving Anti-epileptic Drugs
anti-epileptic drug, Blood sampling - Epilepsy, Drug Hypersensitivity Syndrome
Not applicableCompletedUniversity Hospital, Rouen302013-05-012016-01-25
A Placebo-controlled Study of Efficacy & Safety of 2 Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) & Refractory Partial-onset Seizures
RAD001, Placebo, Antiepileptic drug (1 to 3 only) - Tuberous Sclerosis Complex-associated Refractory Seizures
Phase 3CompletedNovartis Pharmaceuticals3662013-04-292018-11-07
Efficacy of a Simplified Modified Atkins Diet in Children With Refractory Epilepsy
Simplified Modified Atkins Diet, Antiepileptic drugs alone - Refractory Epilepsy
Phase 2 / Phase 3CompletedLady Hardinge Medical College812012-09-012019-01-15
Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures
Placebo, Brivaracetam, Antiepileptic drugs with market authorization available per country - Epilepsy
Phase 3CompletedUCB Pharma7682010-12-012022-07-22
Clinical and Economic Burden of Uncontrolled Epilepsy: Analyses From a Medicaid Database and a Private Health Plan Database
Anti-epileptic drug (AED) - Epilepsy
CompletedGlaxoSmithKline123862010-05-012012-10-08
Preoperative Gabapentine for Carpal Tunnel
Gabapentine, Sugar pill - Carpal Tunnel Syndrome
Phase 3CompletedFederal University of São Paulo402010-03-012019-03-05
Ketogenic Diet vs.Antiepileptic Drug Treatment in Drug Resistant Epilepsy
Ketogenic diet, Antiepileptic drug (AED) - Epilepsy, Mental Retardation
Phase 4UnknownOslo University Hospital602007-11-012009-03-19

Showing 20 of 25. Sign in to see all of them.

Conditions studied

Epilepsy (11)  ·  Seizures (4)  ·  Drug Resistant Epilepsy (3)  ·  Brain Injuries, Traumatic (2)  ·  Wounds and Injuries (2)  ·  Alcoholism (1)  ·  Astrocytoma (1)  ·  Bipolar Disorder (1)  ·  Brain Injuries (1)  ·  Brain Neoplasms (1)  ·  Breast Neoplasms (1)  ·  Carpal Tunnel Syndrome (1)  ·  Chronic Pain (1)  ·  Cognitive Dysfunction (1)  ·  Drug Hypersensitivity Syndrome (1)

Sponsors

Assiut University (1)  ·  Azienda Usl di Bologna (1)  ·  Cyberonics, Inc. (1)  ·  Federal University of São Paulo (1)  ·  Gia Dinh People Hospital (1)  ·  GlaxoSmithKline (1)  ·  Instituto Mexicano del Seguro Social (1)  ·  Istituti Clinici Scientifici Maugeri SpA (1)  ·  Lady Hardinge Medical College (1)  ·  Mayo Clinic (1)  ·  National Cancer Institute (NCI) (1)  ·  National Cancer Institute, Egypt (1)  ·  Novartis Pharmaceuticals (1)  ·  Oslo University Hospital (1)  ·  Peking Union Medical College Hospital (1)

Countries

United States (7)  ·  Italy (5)  ·  Belgium (3)  ·  China (3)  ·  France (3)  ·  Germany (3)  ·  Mexico (3)  ·  United Kingdom (3)  ·  Austria (2)  ·  Canada (2)  ·  Hungary (2)  ·  India (2)  ·  Japan (2)  ·  Netherlands (2)  ·  Norway (2)

Top investigators

Ahmed A Ismail, PhD (1)  ·  Albert Arias, MD (1)  ·  Bjorn Bjurulf, MD (1)  ·  David Peereboom, MD (1)  ·  Evgeny M Krupitsky, MD, PhD (1)  ·  Irit Hochberg, MD/PhD (1)  ·  Ismail A Taha, PhD (1)  ·  Jerome Engel, Jr., M.D., Ph.D. (1)  ·  Lei Ma (1)  ·  Lorenzo Gamberini (1)  ·  Mani Pavuluri, MD (1)  ·  Mark Bunker, PharmD (1)

Results publications

PMID 32588435, PMID 10332020, PMID 10660394, PMID 10742367, PMID 10870204, PMID 10996924, PMID 11188984, PMID 11254763, PMID 11299481, PMID 11971127, PMID 12436398, PMID 1418457, PMID 15816939, PMID 16158066, PMID 16189532, PMID 16499772, PMID 17444813, PMID 17641989, PMID 17642053, PMID 17880009, PMID 17903391, PMID 19889013, PMID 19914135, PMID 22265362, PMID 22278892, PMID 22396514, PMID 25682485, PMID 26471380, PMID 26899665, PMID 27265725, PMID 27335114, PMID 27589414, PMID 27608437, PMID 27613521, PMID 27988967, PMID 28236727, PMID 28279891, PMID 29414542, PMID 29908435, PMID 30169322, PMID 32432339, PMID 33780735, PMID 34155568, PMID 34218211, PMID 34930487, PMID 35285519, PMID 35582748, PMID 36435010, PMID 38788664, PMID 40481521

NIH funding

R21AA026681 (1), U01CA062475 (1)